Navigation Links
MUHC announces a transplant first in Quebec

Doctors at the MUHC have announced Quebec's first successful combined heart/liver transplant. The patient, Patrice Dionne, age 54 years, was transferred from the Institut de cardiologie de Quebec (l'hôpital Laval) to the MUHC. The patient received his new heart and liver during a 6-hour operation on April 14, 2006 and was discharged 10 days later. The complex procedure involved 15 physicians, surgeons and other health care professionals. The MUHC conducts the most organ transplants in Quebec and has the most comprehensive multi-organ transplant program in the province.

"Combined heart/liver transplants are so rare that the best technique for a combined implantation has not yet been elucidated," says Dr. Kevin Lachapelle, a Cardiac Surgeon at the MUHC, who performed the combined procedure with Dr. Peter Metrakos (Liver Surgeon). "Historically these procedures are done separately, but because both organs were procured from Quebec City at the same time by MUHC Drs. Ergina and Paraskevas and because sequential transplants can have a profound negative effect on the heart, we decided a simultaneous implantation offered the best hope of success."

The patient, Patrice Dionne, who was referred to the Institut de cardiologie de Quebec for medical evaluation for a possible heart transplant, was transferred to the MUHC after liver complications necessitated a complex multi-organ transplant. "The patient had waited three years for a heart transplant, during which time his liver began to deteriorate," says Dr. Bernard Cantin, Director of Heart Transplantation at the Institut de cardiologie de Quebec. "At this point we knew the MUHC was the only hospital where we could transfer our patient for this lifesaving surgery." The speed and ease at which this patient transfer occurred demonstrates the level of collaboration and teamwork that exists between hospitals within Quebec.

"The patient made a rapid recovery after surgery, and was discharged after only 10 da ys," says Dr. Nadia Gianetti, Medical Director the Heart Failure and Heart Transplant Program at the MUHC. "The seamless collaboration between the cardiac and liver transplant teams at the MUHC is one of many reasons why the planning, surgery, and follow-up care of Mr. Dionne was so straightforward and uncomplicated." The patient has now fully recovered and is again living a full and rich life. "I am extremely impressed with the doctors at the MUHC; from the onset I had unquestioned confidence in their ability to perform this complex surgery," says Patrice Dionne. "I'm so thankful that I will now be able to enjoy this fathers day with my three sons."

"As a comprehensive Multi-Organ Transplant Program, we are accustomed to collaborating with other institutions across Quebec and other provinces for this form of highly specialized patient care," says Dr. Renzo Cecere, Surgical Director of Heart Failure and Heart Transplantation at the MUHC. "We are particularly pleased to have specialists from every discipline with a strong interest in transplantation, allowing us to successfully offer combined organ transplants within one institution."

The world's first heart transplant was conducted less than forty years ago; complex combined transplants have only been conducted since the 1980's. Multi-organ transplants, such as the combined heart-liver transplant conducted at the MUHC require a multi-specialized team, consisting of cardiologists, hepatologists, intensive care specialists, anesthesiologists, nurses, physiotherapists and Transplant Quebec coordinators. Combined heart-liver transplants are rare--only a few successful procedures have been performed in Canada, and this is the first in Quebec.


'"/>

Source:McGill University


Related biology news :

1. Wiley announces publication of Databasing the Brain
2. Nonlinear Dynamics announces more details of its global partnership with PerkinElmer
3. Neurologix announces positive results of gene therapy clinical trial in Parkinsons disease
4. Eisai announces Phase II data on E7389, a potential new therapy for the treatment of breast cancer
5. GlycoFi announces the first production of antibodies with human glycosylation in yeast
6. NHGRI announces new sequencing targets
7. CHAVI announces international search for genes affecting HIV response
8. NHGRI announces latest sequencing targets
9. St. Jude announces breakthrough in eye cancer treatment
10. NIH announces phase III clinical trial of creatine for Parkinsons disease
11. Discoveries by UAB and Florida scientists may help transplanted organs survive longer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/19/2018)... (PRWEB) , ... December 19, 2018 , ... NDA Partners ... Reviewer and Compliance Officer at the FDA Center for Devices and Radiological Health (CDRH), ... Partners as an Expert Consultant since 2015, and she has more than 25 years ...
(Date:12/18/2018)... ... 18, 2018 , ... Nativis, Inc. , a clinical ... today announced the publication of an early feasibility study in CNS Oncology suggesting ... The publication of the study, An Early Feasibility Study of the Nativis Voyager® ...
(Date:12/13/2018)... ... 12, 2018 , ... NDA Partners Chief Executive Officer Earle ... Consultants, was recently honored by the American Association of Pharmaceutical Scientists (AAPS) with ... science, technology, engineering, or education and whose contributions to the pharmaceutical sciences community ...
Breaking Biology News(10 mins):
(Date:12/18/2018)... ... December 18, 2018 , ... Patients with early stages of breast cancer who ... post-treatment versus whole breast irradiation, a new study suggests. , Patients with early stage ... irradiation after removal of the cancerous tumor because there is a 30 to 40 ...
(Date:12/13/2018)... ... 11, 2018 , ... Researchers at Worcester Polytechnic Institute (WPI) ... Clostridium difficile (C. diff), a dangerous and sometimes fatal gastrointestinal infection. The sensor ... used onsite in doctor’s offices and nursing homes, providing results in minutes instead ...
(Date:12/13/2018)... , ... December 12, 2018 , ... Helping conclude Healthy ... new sleek and slim hearing aid within its Vision and Hearing campaign that sets ... , Studies show that despite continued efforts to destigmatize hearing aids over the ...
(Date:12/10/2018)... Shandong, China and SAN DIEGO (PRWEB) , ... ... ... MabPlex International, Ltd., a fully integrated Contract Development and Manufacturing Organization ... line) development, process characterization, conjugation optimization, cGMP manufacturing, and aseptic fill finish ...
Breaking Biology Technology: